Smead Capital Management disclosed 25 US equity positions worth $128.8m in its Q3 2008 13F filing. Its largest position is MSFT at 12.0% of the reported book, followed by Merck & Co Inc and Accenture Ltd. Versus Q2 2008 it opened 4 new positions, added to 6, reduced 14 and exited 2.
$129m
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
25
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
12.0%
Largest position
The largest single position as a share of the reported equity book.
69.9%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
16
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
75
Quarters on file since Q4 2007
Quarters for which this manager's 13F holdings are on record.